🇺🇸 FDA
Patent

US 11931375

Treatment of amyotrophic lateral sclerosis (ALS)

granted A61KA61K31/713A61K48/005

Quick answer

US patent 11931375 (Treatment of amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/713, A61K48/005, A61K48/0075, A61K9/0085